In addition, reduced fasting serum FGF19 levels have been observed in patients with inflammatory bowel disease, indicating a potential link between FGF19 and oxidative stress, inflammation, and immune response [14, 15], all of which contribute to the pathogenesis of diabetes. Here, FGF19 is linked to diabetes mellitus.